Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS
Clinical trial NCT05779449 · UNKNOWN
Trial details
- NCT number
- NCT05779449
- Sponsor
- Neuromed IRCCS
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2024-11-02
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.